1. Kannan, Kalpana, Coarfa, Cristian, Rajapakshe, Kimal, Milosavljevic, Aleksandar, Yen, Laising. 2014. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma. In PLoS genetics, 10, e1004216. doi:10.1371/journal.pgen.1004216. https://pubmed.ncbi.nlm.nih.gov/24675677/
2. Kim, Seo Rin, Puranik, Amrutesh S, Jiang, Kai, Kirkland, James L, Lerman, Lilach O. 2021. Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy. In Journal of the American Society of Nephrology : JASN, 32, 1987-2004. doi:10.1681/ASN.2020091373. https://pubmed.ncbi.nlm.nih.gov/34135081/
3. Chen, Shaoqiu, Liu, Fangfang, Fu, Yuanyuan, Chu, Qian, Deng, Youping. 2024. A prospective multi-cohort study identifies and validates a 5-gene peripheral blood signature predictive of immunotherapy response in non-small cell lung cancer. In Molecular cancer, 23, 247. doi:10.1186/s12943-024-02160-2. https://pubmed.ncbi.nlm.nih.gov/39506771/
4. Lucci, Valeria, De Marino, Elena, Tagliaferri, Daniela, Falco, Geppino, Angrisano, Tiziana. 2022. Identification of Cdk8 and Cdkn2d as New Prame-Target Genes in 2C-like Embryonic Stem Cells. In Genes, 13, . doi:10.3390/genes13101745. https://pubmed.ncbi.nlm.nih.gov/36292630/
5. Mazzi, Stefania, Dessen, Philippe, Vieira, Mathieu, Raslova, Hana, Vainchenker, William. . Dual role of EZH2 in megakaryocyte differentiation. In Blood, 138, 1603-1614. doi:10.1182/blood.2019004638. https://pubmed.ncbi.nlm.nih.gov/34115825/
智鼠故事 
